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Case reports of women with the rare condition of human seminal plasma allergy have indicated that the condition may be
associated with life-threatening anaphylactic reactions in relation to coitus. Few observations, if any, of long-term outcome of
the condition are available. The aim of this paper was to present a case diagnosed in an 18-year-old girl who presented with
generalized urticaria, nasal congestion and secretion, conjunctivitis, and periorbital and labial oedema 6–8 hours after coitus.
During ﬁve years of followup the condition improved clinically signiﬁcantly. Due to intimacy concerns and the low prevalence of
the condition robust long term data on the natural course of the condition are diﬃcult to obtain. The present case suggests that in
some patients the condition may improve over time.
1.Introduction
Human seminal plasma allergy is an anaphylaxis caused
by immediate hypersensitivity to human seminal plasma.
Around 80 cases have been published since 1958, none of
which have been in adolescents [1]. The condition is con-
sidered to be underreported. Management of the condition
includes abstinence, condom usage, pharmacologic symp-
tomatic treatment, subcutaneous immunotherapy, and local
intravaginal desensitization with human seminal plasma.
Few observations, if any, of long-term outcome of the
condition are available. We report a 5-year followup of a
case of human seminal plasma allergy in a young woman
which suggests that long-term spontaneous improvement
may occur.
2.Case
An 18-year-old woman with a history of eczema during
childhood presented with complaints of episodes of general-
ized urticaria, nasal congestion and secretion, conjunctivitis,
and periorbital and labial oedema 6–8 hours after coitus.
There was no vaginal itching or burning.
Total IgE was slightly elevated, 350 (0–250) KIU/L. The
Phadia Immunocap and the Multiple Allergen Simultaneous
Test-chemiluminescent Assay (MAST CLA) test panels were
negative [2]. Histamine release tests for latex, the partners
saliva, sweat and semen were performed. The histamine
release test procedure includes histamine release from
peripheral whole-blood basophils, in a glass ﬁber prepared
microtiter plate, by challenging 25µL heparinised whole
blood with 25µLb u ﬀered allergen dilutions in various
concentrationsfor60minutesat37◦C.Theassayiscalibrated
by a two-point standard curve and a positive cell control
(anti-IgE) [3]. The test results are given as negative or
positive. Histamine release tests for latex and for the partners
saliva and sweat were negative, whereas the test was positive
forthepartnerssemen.Thepartnerssweat,saliva,andsemen
were also tested in blood from a healthy control person, and
these tests were all negative. Furthermore, a skin prick test
was performed in the patient ﬁnding a positive reaction with
a diameter of 12 (positive control 5) mm for the partners
semen. Skin prick tests with the partners semen were also
performed in two healthy women ﬁnding negative results.
During the ﬁrst 6 months after a diagnosis of anaphylaxis
to human seminal plasma was established, condom usage2 Case Reports in Medicine
was not suﬃcient for prophylaxis. Even close body contact
such as kissing and hugging would cause acute urticaria,
sneezing, and conjunctivitis despite daily intake of oral anti-
histamines, however, life-threatening anaphylactic reactions
did not occur. Sexual intercourse was only possible on
prednisolone 25mg/day; so, the couple opted for abstinence
and slept in separate rooms during most of that period.
Between6and12monthsafterthediagnosis wasestablished,
gradually, body contact became possible, and some months
later with the use of a condom and on premedication with
oral antihistamines coitus was possible without associated
symptoms. During the second and third years after diagnosis
the patient would still use oral antihistamines prior to
intercourse several times per week; however, the condition
was challenged on a regular basis by the couple showing
milder and milder symptoms. Five years after the diagno-
sis incidental episodes of provocation caused by condom
defects and intended challenges without condom were not
associated with signiﬁcant symptoms. A skin prick test in the
patient for the partners semen at that time found a positive
reaction of a diameter of 10 (positive control 7) mm. The
patient did not report any other sexual partners.
3. Discussion
Hypersensitivity to human seminal plasma is deﬁned as a
spectrum of systemic and/or localized symptoms after expo-
sure to speciﬁc protein components in seminal plasma [1].
Thediagnosisisbasedonthemedicalhistoryincombination
with avoidance of symptoms by correct condom usage and
conventional tests of IgE-mediated allergy. Depending on
history diﬀerential diagnoses of hypersensitivity to latex,
spermicidal agents, lubricants, seminal-mediated food chal-
lenges, and microbial causes of vaginal burning and itching
may need to be considered [1]. Absence of symptoms with
condom use is considered the gold standard of diagnosis;
however,asillustratedbythepresentcasecondomusagemay
not be eﬃcient prophylaxis in all cases [4]. The prevalence
of the condition in the unselected population remains
unknown as do implications for sexual health and fertility.
The major antigen is believed to be prostate-speciﬁc antigen,
but other proteins may be involved [5]. The condition is
generally believed to be species-speciﬁc [1]. Women who
develop systemic symptoms are more frequently atopic;
however, signiﬁcant risk factors have not been identiﬁed.
As evidenced by the present case the condition may present
without detectable symptoms of an immediate type 1 allergy
reaction such as vaginal burning or itching. Published cases
so far have been in the 20- to 50-year age group. Most of
them were diagnosed because the women were admitted to
hospital with life-threatening anaphylaxis or because they
were seeking medical advice with a wish for pregnancy.
It is generally believed that the condition is signiﬁcantly
underreported since milder cases do not seek help because
of intimacy concerns. That may also explain why cases in
a d o l e s c e n t sh a v en o tb e e nr e p o r t e du n t i ln o w .Af u r t h e r
explanation may be that in some patients the condition may
improve over time as illustrated by the present case so that
theconditionmaynotsigniﬁcantlyaﬀectlong-termsexuality
or fertility. The present observation of clinical improvement
was not supported by any measures of immunomodulation
such as a shift from a Th2 to a Th1 response, and, indeed,
no such data are available in the literature. Clinical tolerance
may be medically induced over few months by subcutaneous
immunotherapy to relevant fractionated seminal plasma
proteins and by instillation of intravaginal graded challenge
using dilutions of whole seminal ﬂuid from the woman’s
sexual partner [5, 6]. As suggested by the present report
p e r h a p si ns o m ew o m e ns u c hp r o c e d u r e sm a yb ea v o i d e d
unless the patient has an urgent wish for pregnancy. Having
said that, one needs to acknowledge that the possibility
of spontaneous improvement in the unselected population
remains unknown. Due to intimacy concerns and the
low prevalence of the condition robust data are extremely
diﬃcult to obtain.
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